A Segmentation Framework for Accurate Diagnosis of Amyloid Positivity without Structural Images

Penghan Zhu, Shurui Mei, Shushan Chen, Xiaobo Chu, Shanbo He, Ziyi Liu · 2025

Read A Segmentation Framework for Accurate Diagnosis of Amyloid Positivity without Structural Images by Penghan Zhu, Shurui Mei, Shushan Chen, Xiaobo Chu, Shanbo He, Ziyi Liu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2507-22336.txt.

Introduction

Penghan Zhu, Shurui Mei, Shushan Chen, Xiaobo Chu, Shanbo He, and Ziyi Liu diagnose Alzheimer's-related amyloid from brain scans without a structural image, in a 2025 paper. Clinics usually pair PET scans with MRI or CT. That pairing costs time and needs alignment steps. The team's framework segments brain regions from PET alone. A three-dimensional network was trained on two hundred amyloid scans. The data split into training, validation, and test sets.

Segmentation quality varied by region. Deep brain structures scored highest. Uptake measures in key regions matched reference values closely. Some errors were as low as a thousandth of the scale. Classification of amyloid status reached ninety-eight percent accuracy. The curve score was near perfect. The authors propose the tool for places lacking structural imaging. It also removes manual outlining from the pipeline. Clinical validation and more tracer types come next.

Catalog record

CREATORPenghan Zhu, Shurui Mei, Shushan Chen, Xiaobo Chu, Shanbo He, Ziyi Liu
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE18 KB
VERSION1.0
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2507-22336

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

A Segmentation Framework for Accurate Diagnosis of Amyloid Positivity without Structural Images Penghan Zhu, Shurui Mei, Shushan Chen, Xiaobo Chu, Shanbo He, Ziyi Liu Abstract This study proposes a deep learning–based framework for automated segmentation of brain regions and classification of amyloid positivity using positron emission tomography (PET) images alone, without the need for structural MRI or CT. A 3D U-Net architecture with four layers of depth was trained and validated on a dataset of 200 F 18 -florbetapir amyloid-PET scans, with an 130/20/50 train/validation/test split. Segmentation performance was evaluated using Dice similarity coefficients across 30 brain regions, with scores ranging from 0.45 to 0.88, demonstrating high anatomical accuracy, particularly in subcortical structures. Quantitative fidelity of PET uptake within clinically relevant regions. Precuneus, prefrontal cortex, gyrus rectus, and lateral temporal cortex was assessed using normalized root mean square error, achieving values as low as 0.0011. Furthermore, the model achieved a classification accuracy of 0.98 for amyloid positivity based on regional uptake quantification, with an area under the ROC curve (AUC) of 0.99. These results highlight the model’s potential for integration into PET only diagnostic pipelines, particularly in settings where structural imaging is not available. This approach reduces dependence on coregistration and manual delineation, enabling scalable, reliable, and reproducible analysis in clinical and research applications. Future work will focus on clinical validation and extension to diverse PET tracers including C 11 PiB and other F 18 labeled compounds. I Introduction Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by a gradual decline in memory, thinking, and behavior [ 1 ] . While current treatment options offer limited symptomatic relief, no widely available therapies have been proven to effectively modify the disease’s course [ 2 ] . Importantly, the pathological changes associated with AD, most notably, the accumulation of amyloid- \beta (A \beta ) plaques, begins years before the onset of clinical symptoms [ 3 ] . This extended preclinical phase highlights the critical need for early and accurate diagnosis, which is essential for timely intervention and potential disease-modifying treatment. Traditional diagnostic approaches primarily involve clinical assessments [ 3 ] , neuropsychological testing [ 4 ] , and imaging methods that reveal anatomical structures such as magnetic resonance imaging (MRI) [ 5 ] . These techniques are valuable in identifying volumetric changes, including cerebral atrophy or hemorrhage, but are limited in their ability to detect the molecular changes that underlie AD, particularly amyloid pathology [ 6 ] . Positron Emission Tomography (PET) is a functional imaging modality that addresses this gap by visualizing the spatial distribution of A \beta in vivo. PET involves the injection of a radiotracer that selectively binds to A \beta plaques, enabling quantification of amyloid burden in the brain [ 7 ] . To facilitate accurate quantification of tracer uptake, PET images are often coregistered with MRI scans that provide structural reference. However, this multi-modal approach presents challenges. MRI and PET are frequently acquired at different time points due to the limited availability of simultaneous PET/MR systems, leading to potential misalignment between modalities. Moreover, existing PET quantification pipelines either warp standardized templates to individual structural images or vice versa, or register PET images to a common space using ligand-specific templates [ 8 ] . While spatial normalization techniques using PET templates have been proposed, their reliance on ligand-specific templates restricts their applicability to emerging tracers. Manual delineation of regions of interest (ROIs) remains a fallback option, but it is labor-intensive and prone to inter- and intra-observer variability. Figure 1: Visual demonstration of the network architecture. To overcome these limitations, there is a pressing need for methods that can directly extract diagnostically relevant ROIs from PET images alone. Recent advances in artificial intelligence (AI), particularly deep learning (DL), have shown strong potential in medical image analysis tasks such as detection and segmentation [ 9 ] . In this study, we present a novel estimation-based segmentation framework built on a convolutional neural network (CNN) architecture that enables accurate segmentation of ROIs from amyloid-PET images without relying on structural MR or CT images. By doing so, our method facilitates robust and efficient quantification of regional amyloid burden, improves interpretability, and supports automated AD diagnosis, even in the absence of structural imaging data. This approach also accommodates small datasets and provides a generalizable solution for clinical settings where multimodal imaging is not always feasible. II Material and Method II-A Dataset Preparation The study has been carried out with the help of the OASIS3 database. We have selected 200 patients from the database imaged with the F 18 -florbetapir radio tracer. Participants receives a single administration of approximately 10 mCi of AV45. They then were positioned in the PET-MR scanner at the time of injection, and a 70-minute dynamic scan was obtained starting at the time of injection. PET images acquired from 50-70 minutes time window were used for the training and testing of the segmentation model. The time window was selected according to the clinical evaluation protocols. Within the dataset, PET images and MR images are co-registered with the template space of the Montreal Neurological Institute (MNI). The coregistrations are conducted under human inspection for spatial alignments with interpolation of PET images into MR resolution using ITKSnap [ 10 ] . The brain atlas are obtained by the use of FreeSurfer [ 11 ] aligned with the MR images. II-B Convolution Neural Network The CNN model has applied a U-Net architecture that comprises a symmetric encoder-decoder architecture with 4 resolution levels, as shown in Fig. 1 . Each level in the encoder consists of two 3×3 convolutional layers followed by a Rectified Linear Unit (ReLU) activation and a 2×2 max pooling layer for downsampling. The number of feature channels doubles at each downsampling step. At the network bottleneck, two 5×5 convolutions with 1024 feature maps are applied before upsampling begins. The decoder path mirrors the encoder structure. Each upsampling step uses a 2×2 transposed convolution to double the spatial resolution, followed by concatenation with the corresponding feature maps from the encoder. This fusion of contextual and spatial information using skip connection is a core strength of U-Net, inspired by the original Res-Net architecture [ 12 ] . After concatenation, two 3×3 convolutions followed by ReLU activations are applied. A final 1×1 convolutional layer maps the output to the 31 segmentation classes, followed by a softmax activation for multi-class segmentation. A total of 200 amyloid-PET scans were available for model development. The dataset was randomly split into 130 images for training, 20 for validation, and 50 for independent testing. The validation set was used to monitor the model’s performance during training, and an early stopping criterion was applied to prevent overfitting. Specifically, training was halted if the validation loss did not improve for 10 consecutive epochs, and the model with the lowest validation loss was retained as the final model. All experiments were implemented using the PyTorch deep learning framework. Model training and inference were conducted on Google Colab instead of local machines, facilitating GPU acceleration towards efficient network training. The Google Colab environment also allows for rapid prototyping and reproducible results while maintaining accessibility and flexibility for continued development. II-C Evaluation Metrics To assess the performance of the segmentation model, several

Read the complete text